nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.238	0.31	CbGaD
Mianserin—DRD3—attention deficit hyperactivity disorder	0.111	0.145	CbGaD
Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.104	0.135	CbGaD
Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.102	0.132	CbGaD
Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.0775	0.101	CbGaD
Mianserin—DRD2—attention deficit hyperactivity disorder	0.0771	0.1	CbGaD
Mianserin—HTR2A—attention deficit hyperactivity disorder	0.0595	0.0775	CbGaD
Mianserin—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00488	0.076	CbGeAlD
Mianserin—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00471	0.0733	CbGeAlD
Mianserin—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00294	0.0457	CbGeAlD
Mianserin—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.0026	0.0404	CbGeAlD
Mianserin—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.0025	0.0389	CbGeAlD
Mianserin—HTR1F—forebrain—attention deficit hyperactivity disorder	0.00184	0.0287	CbGeAlD
Mianserin—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00156	0.0243	CbGeAlD
Mianserin—HTR6—forebrain—attention deficit hyperactivity disorder	0.00125	0.0195	CbGeAlD
Mianserin—OPRK1—forebrain—attention deficit hyperactivity disorder	0.00116	0.0181	CbGeAlD
Mianserin—HTR1F—nervous system—attention deficit hyperactivity disorder	0.001	0.0156	CbGeAlD
Mianserin—HRH2—cardiovascular system—attention deficit hyperactivity disorder	0.000969	0.0151	CbGeAlD
Mianserin—HTR1F—central nervous system—attention deficit hyperactivity disorder	0.000964	0.015	CbGeAlD
Mianserin—HTR1F—brain—attention deficit hyperactivity disorder	0.000765	0.0119	CbGeAlD
Mianserin—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00075	0.0117	CbGeAlD
Mianserin—HTR1D—forebrain—attention deficit hyperactivity disorder	0.000732	0.0114	CbGeAlD
Mianserin—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000725	0.0113	CbGeAlD
Mianserin—DRD3—nervous system—attention deficit hyperactivity disorder	0.000707	0.011	CbGeAlD
Mianserin—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.000687	0.0107	CbGeAlD
Mianserin—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000681	0.0106	CbGeAlD
Mianserin—HTR6—nervous system—attention deficit hyperactivity disorder	0.000681	0.0106	CbGeAlD
Mianserin—HTR2B—forebrain—attention deficit hyperactivity disorder	0.000681	0.0106	CbGeAlD
Mianserin—HTR6—central nervous system—attention deficit hyperactivity disorder	0.000655	0.0102	CbGeAlD
Mianserin—OPRK1—nervous system—attention deficit hyperactivity disorder	0.00063	0.00981	CbGeAlD
Mianserin—HRH2—nervous system—attention deficit hyperactivity disorder	0.000622	0.00969	CbGeAlD
Mianserin—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000619	0.00963	CbGeAlD
Mianserin—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00061	0.00949	CbGeAlD
Mianserin—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.000607	0.00945	CbGeAlD
Mianserin—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.000605	0.00941	CbGeAlD
Mianserin—HRH2—central nervous system—attention deficit hyperactivity disorder	0.000599	0.00933	CbGeAlD
Mianserin—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.000593	0.00923	CbGeAlD
Mianserin—HTR7—forebrain—attention deficit hyperactivity disorder	0.000583	0.00907	CbGeAlD
Mianserin—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000576	0.00896	CbGeAlD
Mianserin—DRD2—forebrain—attention deficit hyperactivity disorder	0.000551	0.00858	CbGeAlD
Mianserin—Mirtazapine—HRH3—attention deficit hyperactivity disorder	0.000542	0.0941	CrCbGaD
Mianserin—DRD3—brain—attention deficit hyperactivity disorder	0.000541	0.00841	CbGeAlD
Mianserin—HTR6—brain—attention deficit hyperactivity disorder	0.00052	0.0081	CbGeAlD
Mianserin—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000516	0.00803	CbGeAlD
Mianserin—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.000495	0.00771	CbGeAlD
Mianserin—Mirtazapine—ADRA2C—attention deficit hyperactivity disorder	0.000494	0.0859	CrCbGaD
Mianserin—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000493	0.00767	CbGeAlD
Mianserin—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000483	0.00752	CbGeAlD
Mianserin—OPRK1—brain—attention deficit hyperactivity disorder	0.000482	0.0075	CbGeAlD
Mianserin—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000478	0.00745	CbGeAlD
Mianserin—HRH2—brain—attention deficit hyperactivity disorder	0.000476	0.0074	CbGeAlD
Mianserin—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000454	0.00706	CbGeAlD
Mianserin—HRH1—forebrain—attention deficit hyperactivity disorder	0.000435	0.00677	CbGeAlD
Mianserin—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000427	0.00665	CbGeAlD
Mianserin—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000407	0.00633	CbGeAlD
Mianserin—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000403	0.00627	CbGeAlD
Mianserin—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000397	0.00618	CbGeAlD
Mianserin—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000393	0.00612	CbGeAlD
Mianserin—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000392	0.0061	CbGeAlD
Mianserin—HTR7—midbrain—attention deficit hyperactivity disorder	0.000385	0.00599	CbGeAlD
Mianserin—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000383	0.00596	CbGeAlD
Mianserin—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000382	0.00595	CbGeAlD
Mianserin—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000379	0.0059	CbGeAlD
Mianserin—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000377	0.00587	CbGeAlD
Mianserin—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000373	0.0058	CbGeAlD
Mianserin—HTR2B—nervous system—attention deficit hyperactivity disorder	0.00037	0.00575	CbGeAlD
Mianserin—DRD2—midbrain—attention deficit hyperactivity disorder	0.000364	0.00566	CbGeAlD
Mianserin—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000363	0.00566	CbGeAlD
Mianserin—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000359	0.00559	CbGeAlD
Mianserin—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000356	0.00554	CbGeAlD
Mianserin—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000354	0.00551	CbGeAlD
Mianserin—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.000331	0.0575	CrCbGaD
Mianserin—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000331	0.00515	CbGeAlD
Mianserin—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000331	0.00515	CbGeAlD
Mianserin—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000328	0.00511	CbGeAlD
Mianserin—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000319	0.00496	CbGeAlD
Mianserin—HTR7—nervous system—attention deficit hyperactivity disorder	0.000316	0.00493	CbGeAlD
Mianserin—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000316	0.00492	CbGeAlD
Mianserin—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000312	0.00485	CbGeAlD
Mianserin—SLC6A3—brain—attention deficit hyperactivity disorder	0.000311	0.00484	CbGeAlD
Mianserin—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000307	0.00478	CbGeAlD
Mianserin—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000305	0.00474	CbGeAlD
Mianserin—HTR1D—brain—attention deficit hyperactivity disorder	0.000304	0.00473	CbGeAlD
Mianserin—HTR2C—brain—attention deficit hyperactivity disorder	0.000301	0.00468	CbGeAlD
Mianserin—DRD2—nervous system—attention deficit hyperactivity disorder	0.000299	0.00466	CbGeAlD
Mianserin—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000298	0.00463	CbGeAlD
Mianserin—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000291	0.00453	CbGeAlD
Mianserin—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000288	0.00448	CbGeAlD
Mianserin—SLC6A4—brain—attention deficit hyperactivity disorder	0.000285	0.00444	CbGeAlD
Mianserin—HTR2B—brain—attention deficit hyperactivity disorder	0.000282	0.0044	CbGeAlD
Mianserin—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000282	0.00439	CbGeAlD
Mianserin—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000282	0.00438	CbGeAlD
Mianserin—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.00028	0.00436	CbGeAlD
Mianserin—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000274	0.00426	CbGeAlD
Mianserin—Mirtazapine—DRD4—attention deficit hyperactivity disorder	0.000268	0.0466	CrCbGaD
Mianserin—Epinastine—ADRA2A—attention deficit hyperactivity disorder	0.000268	0.0465	CrCbGaD
Mianserin—HTR1A—brain—attention deficit hyperactivity disorder	0.000253	0.00394	CbGeAlD
Mianserin—SLC6A2—brain—attention deficit hyperactivity disorder	0.000251	0.00391	CbGeAlD
Mianserin—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000242	0.00377	CbGeAlD
Mianserin—HTR7—brain—attention deficit hyperactivity disorder	0.000242	0.00376	CbGeAlD
Mianserin—HTR2A—midbrain—attention deficit hyperactivity disorder	0.00024	0.00374	CbGeAlD
Mianserin—HRH1—nervous system—attention deficit hyperactivity disorder	0.000236	0.00368	CbGeAlD
Mianserin—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000233	0.00363	CbGeAlD
Mianserin—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000232	0.00361	CbGeAlD
Mianserin—Mirtazapine—DRD3—attention deficit hyperactivity disorder	0.000231	0.0402	CrCbGaD
Mianserin—DRD2—brain—attention deficit hyperactivity disorder	0.000229	0.00356	CbGeAlD
Mianserin—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000227	0.00354	CbGeAlD
Mianserin—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000223	0.00348	CbGeAlD
Mianserin—ADRA2C—brain—attention deficit hyperactivity disorder	0.000222	0.00346	CbGeAlD
Mianserin—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000218	0.0034	CbGeAlD
Mianserin—Mirtazapine—SLC6A3—attention deficit hyperactivity disorder	0.000215	0.0374	CrCbGaD
Mianserin—Mirtazapine—ADRA2A—attention deficit hyperactivity disorder	0.000211	0.0366	CrCbGaD
Mianserin—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000197	0.00307	CbGeAlD
Mianserin—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.00019	0.00296	CbGeAlD
Mianserin—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000188	0.0326	CrCbGaD
Mianserin—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000186	0.00289	CbGeAlD
Mianserin—CYP2B6—brain—attention deficit hyperactivity disorder	0.000185	0.00288	CbGeAlD
Mianserin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000183	0.00284	CbGeAlD
Mianserin—HRH1—brain—attention deficit hyperactivity disorder	0.000181	0.00281	CbGeAlD
Mianserin—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00018	0.0028	CbGeAlD
Mianserin—ADRA2A—brain—attention deficit hyperactivity disorder	0.000177	0.00276	CbGeAlD
Mianserin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000176	0.00274	CbGeAlD
Mianserin—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000173	0.00269	CbGeAlD
Mianserin—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000169	0.00263	CbGeAlD
Mianserin—Mirtazapine—SLC6A4—attention deficit hyperactivity disorder	0.000161	0.0279	CrCbGaD
Mianserin—Mirtazapine—DRD2—attention deficit hyperactivity disorder	0.00016	0.0278	CrCbGaD
Mianserin—Epinastine—HTR2A—attention deficit hyperactivity disorder	0.000157	0.0273	CrCbGaD
Mianserin—Cyproheptadine—DRD2—attention deficit hyperactivity disorder	0.000155	0.0269	CrCbGaD
Mianserin—HTR2A—brain—attention deficit hyperactivity disorder	0.000151	0.00235	CbGeAlD
Mianserin—CYP2D6—brain—attention deficit hyperactivity disorder	0.000137	0.00214	CbGeAlD
Mianserin—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.000133	0.0231	CrCbGaD
Mianserin—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.00013	0.0227	CrCbGaD
Mianserin—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.00013	0.0226	CrCbGaD
Mianserin—Mirtazapine—HTR2A—attention deficit hyperactivity disorder	0.000124	0.0215	CrCbGaD
Mianserin—Cyproheptadine—HTR2A—attention deficit hyperactivity disorder	0.00012	0.0208	CrCbGaD
Mianserin—Desipramine—SLC6A3—attention deficit hyperactivity disorder	0.000116	0.0202	CrCbGaD
Mianserin—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.000109	0.0189	CrCbGaD
Mianserin—Nortriptyline—SLC6A4—attention deficit hyperactivity disorder	0.000106	0.0184	CrCbGaD
Mianserin—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.000105	0.0183	CrCbGaD
Mianserin—Nortriptyline—DRD2—attention deficit hyperactivity disorder	0.000105	0.0183	CrCbGaD
Mianserin—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	9.95e-05	0.0173	CrCbGaD
Mianserin—Trimipramine—DRD2—attention deficit hyperactivity disorder	9.9e-05	0.0172	CrCbGaD
Mianserin—Imipramine—SLC6A3—attention deficit hyperactivity disorder	9.87e-05	0.0171	CrCbGaD
Mianserin—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	9.61e-05	0.0167	CrCbGaD
Mianserin—Desipramine—SLC6A4—attention deficit hyperactivity disorder	8.7e-05	0.0151	CrCbGaD
Mianserin—Desipramine—DRD2—attention deficit hyperactivity disorder	8.65e-05	0.015	CrCbGaD
Mianserin—Nortriptyline—HTR2A—attention deficit hyperactivity disorder	8.12e-05	0.0141	CrCbGaD
Mianserin—Trimipramine—HTR2A—attention deficit hyperactivity disorder	7.65e-05	0.0133	CrCbGaD
Mianserin—Imipramine—SLC6A4—attention deficit hyperactivity disorder	7.38e-05	0.0128	CrCbGaD
Mianserin—Imipramine—DRD2—attention deficit hyperactivity disorder	7.34e-05	0.0127	CrCbGaD
Mianserin—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	7.33e-05	0.0127	CrCbGaD
Mianserin—Amitriptyline—DRD2—attention deficit hyperactivity disorder	7.29e-05	0.0127	CrCbGaD
Mianserin—Desipramine—HTR2A—attention deficit hyperactivity disorder	6.69e-05	0.0116	CrCbGaD
Mianserin—Imipramine—HTR2A—attention deficit hyperactivity disorder	5.67e-05	0.00985	CrCbGaD
Mianserin—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	5.64e-05	0.00979	CrCbGaD
Mianserin—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.13e-05	7e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.13e-05	7e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.13e-05	6.98e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.13e-05	6.97e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.13e-05	6.97e-05	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.13e-05	6.97e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.12e-05	6.96e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	6.96e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.12e-05	6.95e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.11e-05	6.9e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.11e-05	6.88e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.11e-05	6.87e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.1e-05	6.84e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.1e-05	6.82e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.09e-05	6.76e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.09e-05	6.74e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.08e-05	6.71e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.08e-05	6.7e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.08e-05	6.66e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.07e-05	6.65e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.07e-05	6.63e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.07e-05	6.61e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.07e-05	6.6e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	1.06e-05	6.58e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.06e-05	6.58e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.06e-05	6.56e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.06e-05	6.54e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.05e-05	6.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.05e-05	6.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.05e-05	6.48e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	1.05e-05	6.47e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.04e-05	6.47e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.04e-05	6.45e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.04e-05	6.44e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	6.43e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.04e-05	6.43e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.04e-05	6.42e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.04e-05	6.41e-05	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.04e-05	6.41e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.03e-05	6.4e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.03e-05	6.38e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.03e-05	6.37e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.03e-05	6.35e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.02e-05	6.34e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.02e-05	6.34e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.02e-05	6.33e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.02e-05	6.33e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.02e-05	6.32e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.01e-05	6.26e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.01e-05	6.25e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.01e-05	6.24e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	6.23e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1e-05	6.22e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.92e-06	6.14e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.91e-06	6.14e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.84e-06	6.1e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.77e-06	6.05e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.74e-06	6.04e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.74e-06	6.03e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.72e-06	6.02e-05	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.63e-06	5.97e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.6e-06	5.95e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.59e-06	5.94e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.58e-06	5.93e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.53e-06	5.9e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.46e-06	5.86e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.46e-06	5.86e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.44e-06	5.85e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.44e-06	5.85e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.43e-06	5.84e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.42e-06	5.83e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.4e-06	5.82e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.4e-06	5.82e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.38e-06	5.81e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.37e-06	5.8e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.36e-06	5.8e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.32e-06	5.77e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.31e-06	5.77e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.25e-06	5.73e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	9.18e-06	5.69e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.06e-06	5.61e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.05e-06	5.61e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.03e-06	5.6e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.99e-06	5.57e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.81e-06	5.46e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.77e-06	5.43e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.75e-06	5.42e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.74e-06	5.41e-05	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.7e-06	5.39e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.69e-06	5.38e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.68e-06	5.37e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	8.63e-06	5.35e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.63e-06	5.35e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.62e-06	5.34e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.62e-06	5.34e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.55e-06	5.3e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.51e-06	5.27e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.49e-06	5.26e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	8.49e-06	5.26e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.42e-06	5.22e-05	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.39e-06	5.2e-05	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.35e-06	5.17e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.18e-06	5.07e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.15e-06	5.05e-05	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.12e-06	5.03e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	8.09e-06	5.01e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.09e-06	5.01e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.09e-06	5.01e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.02e-06	4.97e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	7.96e-06	4.93e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.93e-06	4.91e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.93e-06	4.91e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.93e-06	4.91e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.92e-06	4.9e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.9e-06	4.89e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.9e-06	4.89e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.89e-06	4.89e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.85e-06	4.87e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.8e-06	4.83e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.79e-06	4.82e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.64e-06	4.73e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.62e-06	4.72e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.6e-06	4.71e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.58e-06	4.7e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.4e-06	4.58e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.38e-06	4.57e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.38e-06	4.57e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.37e-06	4.56e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.36e-06	4.56e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.34e-06	4.55e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.3e-06	4.52e-05	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	7.29e-06	4.52e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.24e-06	4.48e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.24e-06	4.48e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.15e-06	4.43e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.11e-06	4.4e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.1e-06	4.4e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.1e-06	4.4e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.07e-06	4.38e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.99e-06	4.33e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.95e-06	4.31e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.93e-06	4.29e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.9e-06	4.28e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.9e-06	4.27e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.9e-06	4.27e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.88e-06	4.26e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.87e-06	4.25e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.82e-06	4.23e-05	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	6.81e-06	4.22e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.81e-06	4.22e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.76e-06	4.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.69e-06	4.15e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.68e-06	4.14e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.66e-06	4.13e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.6e-06	4.09e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.57e-06	4.07e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.47e-06	4.01e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.44e-06	3.99e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	6.44e-06	3.99e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.43e-06	3.98e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.4e-06	3.96e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	6.39e-06	3.96e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.34e-06	3.93e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.33e-06	3.92e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.24e-06	3.87e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.22e-06	3.85e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.21e-06	3.84e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.17e-06	3.82e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.16e-06	3.81e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.14e-06	3.8e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.14e-06	3.8e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.13e-06	3.8e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.08e-06	3.77e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.08e-06	3.76e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.06e-06	3.75e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.04e-06	3.74e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.04e-06	3.74e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.02e-06	3.73e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.99e-06	3.71e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.96e-06	3.69e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.95e-06	3.69e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.77e-06	3.57e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	5.62e-06	3.48e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.62e-06	3.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.59e-06	3.46e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.55e-06	3.44e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.55e-06	3.44e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.54e-06	3.43e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	5.53e-06	3.43e-05	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	5.53e-06	3.43e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.42e-06	3.36e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.42e-06	3.36e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.33e-06	3.3e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	5.23e-06	3.24e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	5.19e-06	3.22e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.17e-06	3.2e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.14e-06	3.19e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.05e-06	3.13e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5e-06	3.1e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	4.9e-06	3.04e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.87e-06	3.02e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	4.76e-06	2.95e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.76e-06	2.95e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	4.69e-06	2.9e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.66e-06	2.89e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.5e-06	2.79e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.5e-06	2.78e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.48e-06	2.77e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.36e-06	2.7e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.36e-06	2.7e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.28e-06	2.65e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.2e-06	2.6e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.95e-06	2.45e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.88e-06	2.4e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.81e-06	2.36e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	3.68e-06	2.28e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.68e-06	2.28e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.63e-06	2.25e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	3.62e-06	2.24e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.54e-06	2.19e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	3.41e-06	2.11e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	3.38e-06	2.1e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.36e-06	2.08e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.27e-06	2.03e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.22e-06	2e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.22e-06	1.99e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.2e-06	1.98e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.94e-06	1.82e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.94e-06	1.82e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.89e-06	1.79e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.87e-06	1.78e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.8e-06	1.73e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.78e-06	1.72e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	2.76e-06	1.71e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.74e-06	1.7e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.47e-06	1.53e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.39e-06	1.48e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.37e-06	1.47e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.31e-06	1.43e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	2.24e-06	1.39e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.23e-06	1.38e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.21e-06	1.37e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	2.1e-06	1.3e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.09e-06	1.3e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.06e-06	1.28e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.06e-06	1.27e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.87e-06	1.16e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.46e-06	9.05e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.24e-06	7.67e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	9.55e-07	5.92e-06	CbGpPWpGaD
